- Jefferies upgraded Avantor (NYSE: AVTR) to a 'Hold' rating with a $13.00 price target, suggesting a potential 9.6% downside from its recent trading price of $14.38.
- Avantor reported $1.69 billion in revenue, a 0.5% increase year-over-year, beating analyst expectations by 4.17%. However, adjusted EPS decreased to $0.21 from $0.24 despite beating estimates by 10.53%.
- The company raised its full-year 2026 financial guidance and generated $142.8 million in free cash flow, using $112.1 million to repay debt.
Avantor (NYSE: AVTR) is a global company that provides essential products and services to customers in the life sciences and advanced technology industries. Operating within the competitive medical services sector, Avantor supplies critical materials and solutions for research, development, and production activities. The company supports diverse fields ranging from biopharma to healthcare and education.
On July 29, 2026, a prominent analyst from Jefferies issued an analyst upgrade, moving Avantor to a 'Hold' stock rating from 'Underperform'. The firm also set a price target of $13.00 per share. At the time, Avantor stock was trading at $14.38, meaning the analyst's target suggests a potential downside of about 9.6% from its recent stock price.
This analyst rating change follows Avantor's strong second-quarter 2026 financial report. The company posted revenue of $1.69 billion, which represents a 0.5% increase from the same period last year. This revenue growth figure beat analyst expectations by 4.17%, as highlighted by Zacks Equity Research. This significant outperformance in Q2 earnings likely contributed to the improved analyst rating.
Despite the positive revenue surprise, the analyst's caution regarding Avantor's stock performance may stem from other key metrics. Avantor's adjusted Earnings Per Share (EPS), a crucial measure of profitability, was $0.21. While this figure beat estimates by 10.53%, it marks a decrease from the $0.24 reported in the prior year's quarter. The company also experienced a slight organic revenue decline of 0.4%.
Following these Q2 results, Avantor raised its financial guidance for the full year of 2026, signaling confidence in its future financial performance. The company also generated a robust $142.8 million in free cash flow, strategically using $112.1 million for debt repayment. Avantor's CEO highlighted that the company's overall performance exceeded expectations, with its distribution segment returning to growth sooner than anticipated.